Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | NUVL | IBRX | ||
| Company | Blueprint Medicines Corp | Nuvalent Inc Cl A | Immunitybio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 107.77 | 8.27 | ||
| High | 129.55 | 109.53 | 8.38 | ||
| Low | 129.30 | 105.76 | 7.75 | ||
| Latest | 129.46 | 108.85 | 8.07 | ||
| Change | +0.18 | +1.72 | -0.03 | ||
| % Change | +0.14% | +1.61% | -0.37% | ||
| Volume | 2,980,900 | 581,400 | 11,414,400 | ||
| 20-Day Average Volume | 4,470,280 | 625,350 | 17,390,990 | ||
| Previous Close | 129.28 | 107.13 | 8.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 103.52 | 7.46 | ||
| 20-Day Raw Stochastic | 88.49% | 95.12% | 75.38% | ||
| 20-Day Relative Strength | 73.17 | 59.92 | 53.17 | ||
| Weighted Alpha | +17.08 | +47.58 | +24.98 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +3.91% since 04/15/26 | +3.73% since 04/15/26 | ||
| Low | 129.00 on 07/11/25 | 101.79 on 04/16/26 | 7.12 on 04/16/26 | ||
| High | 129.65 on 07/16/25 | 109.53 on 04/22/26 | 8.56 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +14.86% since 03/20/26 | -4.72% since 03/20/26 | ||
| Low | 128.00 on 06/20/25 | 93.91 on 03/24/26 | 6.54 on 03/24/26 | ||
| High | 129.65 on 07/16/25 | 109.53 on 04/22/26 | 9.54 on 03/23/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | -2.80% since 01/22/26 | +9.95% since 01/22/26 | ||
| Low | 83.27 on 04/22/25 | 93.91 on 03/24/26 | 5.54 on 01/28/26 | ||
| High | 129.65 on 07/16/25 | 111.28 on 01/23/26 | 12.43 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +19.77% since 10/22/25 | +241.95% since 10/22/25 | ||
| Low | 73.04 on 04/09/25 | 89.02 on 11/05/25 | 1.95 on 12/31/25 | ||
| High | 129.65 on 07/16/25 | 113.01 on 01/22/26 | 12.43 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,422,238 | 8,327,700 | ||
| Shares Outstanding, K | 64,582 | 78,617 | 1,028,111 | ||
| Annual Sales | 508,820,000 | 0 | 113,290,000 | ||
| Annual Net Income | -67,090,000 | -425,380,000 | -351,400,000 | ||
| Last Quarter Sales | 149,410,000 | 0 | 38,290,000 | ||
| Last Quarter Net Income | 500,000 | -118,710,000 | -61,940,000 | ||
| 60-Month Beta | 0.89 | 1.31 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | -1.29 on 02/26/26 | -0.06 on 02/23/26 | ||
| Latest Earnings Date | 08/07/25 | 05/14/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||